Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combining Pregabalin (LYRICA®) With Lofexidine (LUCEMYRATM): Can it Increase the Success of Transition to Naltrexone?

NCT04218240 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT04218240
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04218240 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combining Pregabalin (LYRICA®) With Lofexidine (LUCEMYRATM): Can it Increase the Success of Transition to Naltrexone?
Lead sponsor
University of Pennsylvania
Phase
Phase 2
Overall status
Completed
Start date
December 17, 2020
Completion date
August 31, 2023
Enrollment
90 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

opioid withdrawal